Active Ingredient
Miconazole Nitrate USP 2.0%
The following Structured Product Label (SPL) was submitted to the FDA by Aldermed Inc. for the product Miconazole Cream (NDC 87236-013). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, do not use, when using this product, stop use and ask a doctor, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Miconazole Nitrate USP 2.0%
Antifungal
For external use only
■ irritation oc:curs
■ there is no improvement within 2 weeks when used for the treatment of jock itch
■ there is no improvement within 4 weeks when used for athlete's foot and ringworm
If swallowed, get medical help or contact a Poison Control Center right away (1-800-222-1222)
■ clean the affected area and dry thoroughly
■ apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor
■ supervise children in the use of this product
■ for athlete's foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily
■ for athlete's foot and ringworm, use daily for 4 weeks
■ for jock itch, use daily for 2 weeks
■ if condition persists longer, consult a doctor
■ this product is not effective on the scalp or nails
■ to open: unscrew cap, pull tab to remove foil seal
■ store at 20° to 25°C (68° to 77°F)
■preserve in tight container
■ see tube crimp for lot number and expiration date
cetostearyl alcohol, chlorocresol, edetate disodium, light mineral oil, macrogol cetostearyl ether, propylene glycol, purified water, sodium phosphate dibasic dihydrate, sodium phosphate monobasic dihydrate, white petrolatum, zinc oxide.
Call 1-833-605-8474 9am-5pm EST M-F
* Please review the disclaimer below.